Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zlatanou

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Oncogene|May 12, 2015
USP7 is essential for maintaining Rad18 stability and DNA damage toleranceA Zlatanou, S Sabbioneda, E S Miller, et al.
Oncogene|August 19, 2014
The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53A Thomas, T Perry, S Berhane, et al.
Blood Cancer Journal|July 23, 2013
BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemiaD Da Costa, A Agathanggelou, T Perry, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Oncogene|May 12, 2015
USP7 is essential for maintaining Rad18 stability and DNA damage toleranceA Zlatanou, S Sabbioneda, E S Miller, et al.
Oncogene|August 19, 2014
The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53A Thomas, T Perry, S Berhane, et al.
Blood Cancer Journal|July 23, 2013
BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemiaD Da Costa, A Agathanggelou, T Perry, et al.
Pageof 1